Latest It Compliance News

Antares Metals has confirmed significant high-grade uranium mineralisation at its Queens Gift project in Queensland, setting the stage for a resource upgrade and expanded exploration across its Mt Isa North portfolio.

Atlas Pearls Ltd has disclosed a significant 27% revenue decline and a net loss for the half year ended December 2025, attributing the results to weaker auction outcomes and one-off accounting impacts. The company affirms timely disclosure and compliance with ASX rules amid market sensitivity.

TZ Limited has responded to ASX queries over the deferral of a A$2.75 million debt repayment, asserting the delay was already well disclosed and unlikely to impact its share price materially.

Terramin Australia has withdrawn previously released estimates on the South Gawler Ranges Project, citing non-compliance with JORC standards and urging investors to disregard the earlier figures.

Aerometrex has won multiple government contracts worth $2.5 million over three years, reinforcing its position as a trusted local provider and enhancing revenue visibility.

NH3 Clean Energy has received multiple engineering proposals for the Front End Engineering and Design (FEED) of its WAH2 clean ammonia project and commenced a detailed flora survey, marking significant progress toward its Final Investment Decision by year-end.

St George Mining has appointed Carla Grasso as Principal Geologist to spearhead mine planning at its Araxá Rare Earths-Niobium Project, following a major resource upgrade. This move signals a decisive step towards advancing economic studies and potential mining operations in Brazil.

Sports Entertainment Group Limited has announced a significant on-market share buy-back program, aiming to repurchase up to 10% of its shares over the next year starting March 2026. The move reflects the board's confidence in the company's underlying value amid current market pricing.

FleetPartners Group Limited has announced a $20 million on-market share buy-back, reinforcing its strong balance sheet and commitment to shareholder returns alongside its existing dividend policy.

EVE Health Group has completed R&D on multiple reformulated drug candidates targeting major sexual health and cardiovascular markets, preparing patent filings and licensing strategies to capitalise on a combined $30 billion global opportunity.

Queste Communications Ltd reported a positive net cash flow from operating activities for February 2026, supported by a robust cash balance and stable financing arrangements. The company’s consolidated position, including its majority stake in Orion Equities, underscores its solid liquidity outlook.

Cyclopharm Limited has responded to ASX queries clarifying the material significance of its Technegas® contract with the US National Institutes of Health, while confirming robust progress in expanding its US footprint.